Organon CEO Resigns Amid Sales Malpractice Probe
Organon CEO Kevin Ali has stepped down from his position after the company's board discovered sales malpractice.
An investigation by the board's audit committee found evidence of malpractice, resulting in "inaccurate or incomplete" sales statements.
- The probe revealed "improper" wholesaler sales practices, including encouraging US-based wholesalers to buy more of the company's contraceptive implant, Nexplanon, than needed.
The company's actions were found to be "inaccurate or incomplete" by the board's audit committee.
The incident has led to Ali's resignation and the termination of another employee.
Author's summary: Organon CEO Kevin Ali resigns amid sales probe.
More News
- Mystery of The Ocean's Missing Plastic a Step Closer to Being Solved
- Tonight’s ‘Sports Equinox’ will showcase games throughout the NFL, MLB, NBA and NHL
- Global PAH data shows rising cases and risk factors in elderly
- READY, FIRE, AIM: Fly Me to the Moon – Pagosa Daily Post News Events & Video for Pagosa Springs Colorado
- Leptin neural circuit restores balance after anxiety upsets it
- AMD Ryzen 10 and 100 Series Rebrand Older Zen 2 and Zen 3+ Chips
- Why Hiring a Fishers Personal Injury Lawyer Is Key After a Car Accident, Slip, or Dog Bite | NorthPennNow
- Skyline Nav AI's software can guide you anywhere, without GPS — find it at TechCrunch Disrupt 2025 | TechCrunch
- UO’s celebration of Indigenous lives - Daily Emerald
- West Indies ease past Bangladesh in first T20I